APA
McArthur J. H., Durbin A. P., Marron J. A., Wanionek K. A., Thumar B., Pierro D. J., Schmidt A. C., Blaney J. E., Murphy B. R. & Whitehead S. S. (20081124). Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. : The American journal of tropical medicine and hygiene.
Chicago
McArthur Julie H, Durbin Anna P, Marron Jennifer A, Wanionek Kimberli A, Thumar Bhavin, Pierro Dennis J, Schmidt Alexander C, Blaney Joseph E, Murphy Brian R and Whitehead Stephen S. 20081124. Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. : The American journal of tropical medicine and hygiene.
Harvard
McArthur J. H., Durbin A. P., Marron J. A., Wanionek K. A., Thumar B., Pierro D. J., Schmidt A. C., Blaney J. E., Murphy B. R. and Whitehead S. S. (20081124). Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. : The American journal of tropical medicine and hygiene.
MLA
McArthur Julie H, Durbin Anna P, Marron Jennifer A, Wanionek Kimberli A, Thumar Bhavin, Pierro Dennis J, Schmidt Alexander C, Blaney Joseph E, Murphy Brian R and Whitehead Stephen S. Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity. : The American journal of tropical medicine and hygiene. 20081124.